MARKET WIRE NEWS
  1. Home
  2. Stock
  3. CTXR
  4. News
CTXR
Quote
Short
News
Articles
Message Board

Citius Pharmaceuticals Inc. (NASDAQ : CTXR ) News

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) News Releases

CTXR News Releases
CTXR : NASDAQ
PR Newswire
Citius Oncology Announces Positive Topline Results from Investigator?Initiated Phase 1 Study of LYMPHIR(TM) in Combination with Pembrolizumab in Relapsed or Refractory Gynecologic Cancers
CTXR : NASDAQ
PR Newswire
Citius Pharmaceuticals, Inc. Secures $3.8 million through New Jersey Economic Development Program
CTXR : NASDAQ
PRISM News
Citius Pharmaceuticals Reports First Revenue Following LYMPHIR(TM) Launch
CTXR : NASDAQ
PR Newswire
Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR(TM)
CTXR : NASDAQ
PR Newswire
Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR(TM)
CTXR : NASDAQ
PR Newswire
Citius Oncology Expands International Distribution of LYMPHIR(TM) to European Union Through Exclusive Agreement with Uniphar
CTXR : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Morning edition
Fri, Dec 26, 2025 as of 10.00 am ET
CTXR : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Evening edition
Wed, Dec 24, 2025 as of 4:00 pm ET
CTXR : NASDAQ
SeekingAlpha
Citius Pharmaceuticals GAAP EPS of -$3.38
CTXR : NASDAQ
SeekingAlpha
Citius Pharmaceuticals GAAP EPS of -$3.38 misses by $0.25

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.